Status:

UNKNOWN

Three Dimensional Navigation IntraCardiac Guidance Kit for Atrial Septal Puncture

Lead Sponsor:

Tongji Hospital

Collaborating Sponsors:

Wuhan Greenrhythm Medical Technology Co., LTD

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

This study aims to evaluate the safety and efficacy of a three-dimensional navigation intracardiac guidance kit to perform atrial septal puncture in patients requiring catheter ablation, which will be...

Detailed Description

Atrial septal puncture has become a key technique in cardiac interventional procedures. Traditional septal punctures are routinely perfomed under two-dimensioanl guidance, whic are likely to be not ac...

Eligibility Criteria

Inclusion

  • Diagnosed with atrial fibrillation.
  • Requiring catheter ablation therapy.
  • Voluntarily sign the informed consent.

Exclusion

  • Previous atrial septal puncture.
  • Blood clots in the left atrium or left atrial appendage
  • Left atrial mucinous tumor.
  • Atrial septal defect, including previous surgical correction or interventional occlusion.
  • Acute or severe systemic infection.
  • Cardiac function (NYHA classification) Ⅲ-Ⅳ.
  • Contraindications to anticoagulation.
  • Left ventricular ejection fraction \<35%.
  • Patients with untreated or uncontrolled hyperthyroidism or hypothyroidism.
  • Patients with malignancy with expected survival of less than 1 year.
  • Myocardial infarction or any cardiac intervention or open procedure within the last 3 months
  • Stroke and other cerebrovascular disease or thromboembolic disease within the last 3 months.
  • Participated in clinical trials of other drugs or devices in the past 3 months.
  • Any other condition that the investigator deems inappropriate for participation in this trial.

Key Trial Info

Start Date :

April 24 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2024

Estimated Enrollment :

136 Patients enrolled

Trial Details

Trial ID

NCT06188351

Start Date

April 24 2023

End Date

September 1 2024

Last Update

January 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tongji Hospital

Wuhan, Hubei, China, 430030